Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Clinical trials of recombinant human GH therapy in Turner syndrome that began more than a decade ago show that GH accelerates the linear growth rate. Several studies indicate that final height is also improved, although the magnitude of the increase has been debated. The age at which feminization is induced could be an important factor in determining the patient’s ultimate growth response. To test this, 60 patients from a large (n = 117), previously unreported, clinical trial of GH treatment were randomly assigned to begin conjugated estrogens at either 12 or 15 yr of age. The 60 patients were all less than 11 yr of age at entry (mean, 9.5 yr) and received 0.375 mg/kg·week of GH for nearly 6 yr on a daily or three times weekly regimen. Height gain was calculated by comparing the study patients’ final or near final heights to their pretreatment projected heights as well as to those of a separate set of age-matched, historical control patients. Patients in whom estrogen treatment was delayed until age 15 yr...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variations in pattern of pubertal changes in girls
Marshall, W. A., & Tanner, J. M. (1969) · Archives of Disease in Childhood · doi:10.1136/adc.44.235.291 · Cited by 5,963
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height
Rosenfeld, R. G., Attie, K. M., Frane, J., Brasel, A., Burstein, S., Cara, J. F., Chernausek, S., Gotlin, R. W., Kuntze, J., Lippe, B. M., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70452-4 · Cited by 265
Self-citationBlethen, S. L., Allen, D. B., Graves, D., August, G., Moshang, T., & Rosenfeld, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626820 · Cited by 246
Growth hormone secretory dynamics in Turner syndrome
Ross, J. L., Long, L. M., Loriaux, D. L., & Cutler, G. B. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80287-0 · Cited by 156
Cited by
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
“Delaying estrogen therapy until 15 yr of age to optimize height potential, as previously recommended (115), seems unwarranted.”
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Recommendations for the Diagnosis and Management of Turner Syndrome1
Saenger, P., Wikland, K. A., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7683 · Cited by 351
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Growth hormone plus childhood low-dose estrogen in Turner's syndrome
Ross, J. L., Quigley, C. A., Cao, D., Feuillan, P., Kowal, K., Chipman, J. J., & Cutler, G. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005669 · Cited by 212
Prevalence and Clinical Picture of Celiac Disease in Turner Syndrome
Bonamico, M., Pasquino, A. M., Mariani, P., Danesi, H. M., Culasso, F., Mazzanti, L., Petri, A., & Bona, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020855 · Cited by 183
Quigley, C. A., Crowe, B. J., Anglin, D. G., & Chipman, J. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8477 · Cited by 159
“1 cm (18) to over 10 cm ( 19 ) or even complete normalization of height (20).”
BackgroundCarel, J.-C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Cabrol, S., Nicolino, M., Brauner, R., Chaussain, J.-L., & Coste, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2652 · Cited by 152
Davenport, M. L., Crowe, B. J., Travers, S. H., Rubin, K., Ross, J. L., Fechner, P. Y., Gunther, D. F., Liu, C., Geffner, M. E., Thrailkill, K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2874 · Cited by 147
Nordenström, A., Ahmed, S. F., van den Akker, E., Blair, J., Bonomi, M., Brachet, C., Broersen, L. H. A., Claahsen-van der Grinten, H. L., Dessens, A. B., Gawlik, A., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0073 · Cited by 108
Gault, E. J., Perry, R. J., Cole, T. J., Casey, S., Paterson, W. F., Hindmarsh, P. C., Betts, P., Dunger, D. B., Donaldson, M. D. C., & on behalf of the British Society for Paediatric Endocrinology and Diabetes (2011) · BMJ · doi:10.1136/bmj.d1980 · Cited by 71
Linglart, A., Cabrol, S., Berlier, P., Stuckens, C., Wagner, K., de Kerdanet, M., Limoni, C., Carel, J.-C., Chaussain, J.-L., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1048 · Cited by 61
Quigley, C. A., Wan, X., Garg, S., Kowal, K., Cutler, G. B., & Ross, J. L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4518 · Cited by 56
Turner's syndrome: challenges of late diagnosis
Lee, M. C., & Conway, G. S. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70153-0 · Cited by 48
Cameron-Pimblett, A., Davies, M. C., Burt, E., Talaulikar, V. S., La Rosa, C., King, T. F. J., & Conway, G. S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02137 · Cited by 40
Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect
Wasniewska, M., De Luca, F., Bergamaschi, R., Guarneri, M., Mazzanti, L., Matarazzo, P., Petri, A., Crisafulli, G., Salzano, G., & Lombardo, F. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510567 · Cited by 30
“However, Chernausek et al. ( 17 ) have found that the number of years on GH therapy prior to the introduction of estrogen was a strong predictor of the entire height gain (the equation was”
BackgroundQuigley, C. A., Fechner, P. Y., Geffner, M. E., Eugster, E. A., Ross, J. L., Habiby, R. L., Ugrasbul, F., Rubin, K., Travers, S., Antalis, C. J., et al. (2021) · Hormone Research in Paediatrics · doi:10.1159/000513788 · Cited by 25
Labarta, J. I., Moreno, M. L., López-Siguero, J. P., Luzuriaga, C., Rica, I., Sánchez-del Pozo, J., & Gracia-Bouthelier, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0444 · Cited by 24
Bettendorf, M., Inta, I. M., Doerr, H. G., Hauffa, B. P., Mehls, O., & Ranke, M. B. (2013) · Hormone Research in Paediatrics · doi:10.1159/000356045 · Cited by 17
Kriström, B., Ankarberg-Lindgren, C., Barrenäs, M.-L., Nilsson, K. O., & Albertsson-Wikland, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1197897 · Cited by 11
Metadata
- Authors
- Chernausek, S. D.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-07-01
- Volume
- 85
- Issue
- 7
- Pages
- 2439-2445
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1990329176
- Cited by
- 130
- References
- 5
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.